120 related articles for article (PubMed ID: 2325680)
1. Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion.
Rodriguez ME; Luquin MR; Lera G; Delgado G; Salazar JM; Obeso JA
Mov Disord; 1990; 5(2):170-2. PubMed ID: 2325680
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
[TBL] [Abstract][Full Text] [Related]
3. Intravenous lisuride in the treatment of the neuroleptic malignant syndrome.
Sczesni B; Bittkau S; von Baumgarten F; von Schröder J; Suchy I; Przuntek H
J Clin Psychopharmacol; 1991 Jun; 11(3):185-8. PubMed ID: 2066456
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
5. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine and lisuride in Parkinson disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E
Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164
[TBL] [Abstract][Full Text] [Related]
7. [Lisuride in the combination treatment of Parkinson disease].
Jellinger K
Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome].
Sczesni B; Schröder J; Becker H; Przuntek H
Wien Klin Wochenschr; 1991; 103(1):1-7. PubMed ID: 1673041
[TBL] [Abstract][Full Text] [Related]
10. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic malignant syndrome].
Murak E
Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
Stracke H; Heinlein W; Horowski R; Schatz H
Arzneimittelforschung; 1986 Dec; 36(12):1834-6. PubMed ID: 3566845
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Yamawaki Y; Ogawa N
Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
[TBL] [Abstract][Full Text] [Related]
14. Management of neuroleptic malignant syndrome--a series of eight cases.
Kurien T; Rajeev KK; Abraham OC; Archana S; Cherian AM
J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521
[TBL] [Abstract][Full Text] [Related]
15. Lisuride in the treatment of Parkinsonism.
Schachter M; Sheehy MP; Parkes JD; Marsden CD
Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
17. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Stocchi F; Ruggieri S; Brughitta G; Agnoli A
J Neural Transm Suppl; 1986; 22():209-18. PubMed ID: 3465872
[TBL] [Abstract][Full Text] [Related]
18. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Obeso JA; Luquin MR; Martínez Lage JM
Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037
[TBL] [Abstract][Full Text] [Related]
19. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
20. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.
Khan A; Jaffe JH; Nelson WH; Morrison B
J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
